Back to results
US 8,278,337 B2Granted
Substituted pyridines that are JNK inhibitors
AssigneeMerck Sharp & Dohme Corp.
InventorsDavid B. Belanger, M. Arshad Siddiqui, Patrick J. Curran, Blake Hamann, Lianyun Zhao, Panduranga Adulla P. Reddy, Praveen K. Tadikonda, Gerald W. Shipps, Jr., Umar Faruk Mansoor
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of the formula (I) wherein X is N or CH, and Y is N or CR5. Also disclosed are methods of treating JNK and ERK mediated diseases using the compounds of formula 1.0.
Claims25
A compound of the formula:
- or pharmaceutically acceptable salts or esters thereof, wherein
- X is N;
- Y is CR5 wherein R5 is H;
- R1A is H;
- R2A is H;
- R3 is —C(O)NR8R9;
- R4 is —C(O)NR6R7;
- R6 is H;
- R7 is alkyl;
- R8 is H;
- R9 is selected from the group consisting of:
- (1) heteroarylalkyl-, and
- (2) substituted heteroarylalkyl wherein said substituted heteroarylalkyl is substituted with 1 to 3 substituents independently selected from the group consisting of:
- (a) —NH2,
- (b) —NH(C1 to C6)alkyl,
- (c) —N((C1 to C6)alkyl)2 wherein each alkyl is independently selected,
- (d) alkyl,
- (e) halo,
- (f) aryl,
- (g) substituted aryl wherein said substituted aryl is substituted with 1 to 3 substituents independently selected from the group consisting of:
- (i) —SO2R20, (ii) —OR21, (iii) -halo, (iv) —CN, (v) —CF3, (vi) aminoalkyl-, (vii) —S(O)R26, and (viii) alkyl,
- (h) heterocycloalkyl,
- (i) heteroaryl,
- (j) substituted aryl substituted with 1 to 3 substituents independently selected from the group consisting of:
- alkyl, —CF3, F, Cl, and Br,
- (k) substituted heteroaryl, substituted with 1 to 3 substituents selected from the group consisting of:
- (i) alkyl, (ii) halo, (iii) CN, (iv) NH2, (v) —NH(C1-C6 alkyl), (vi) —N(C1-C6 alkyl)2 wherein each alkyl is independently selected, (vii) —CF3, (viii) substituted aryl wherein said substituted aryl is substituted with 1 to 3 substitutents independently selected from the group consisting of:
- —S(O)2R42 and —CN, and (ix) —C(O)NR44R46,
- (l) alkylamino-,
- (m) heterocycloalkyl-alkyl-amino-,
- (n) alkylaminoalkylamino-,
- (o) —NHC(O)OR30, and
- (p) —NHC(O)NR32R34;
- R20 is selected from the group consisting of:
- (1) alkyl, (2) dialkylamino (wherein each alkyl is independently selected), (3) —NH2, (4) alkylamino, (5) heterocycloalkyl, and (6) substituted heterocycloalkyl wherein said substituted heterocycloalkyl is substituted with 1 to 2 substitutents independently selected from the group consisting of:
- —C(O)OR40;
- R21 is alkyl;
- R26 is alkyl;
- R30 is alkyl;
- Each R32 and R34 is independently selected from the group consisting of:
- H, alkyl, aryl, aryl substituted with a —OH group, and heteroaryl;
- R40 is alkyl;
- and
- Each R44 and R46 is independently selected from the group consisting of:
- H and alkyl.
42 more elements
A compound selected from the group consisting of:
- Compound
- 102
- 103
- 105
- 116
- 117
- 119
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 210
- 213
- 216
- 219
- 222
- 228
- 233
- 234
- 235
- 236
- 241
- 244
- 245
- 246
- 247
- 248
- 309
- and
- 310
56 more elements
A compound selected from the group consisting of:
- Compound
- 5
- 7
- 8
- 13
- 14
- 47
- 53
- 64
- 65
- 71
- 85
- 86
- 87
- 92
- 93
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 171
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 200
- 201
- 202
- 203
- 205
- 206
- 207
- 210
- 213
- 216
- 219
- 222
- 228
- 233
- 234
- 235
- 238
- 241
- 244
- 245
- 246
- 247
- 248
- 254
- 255
- 256
- 257
- 258
- 309
- and
- 310
112 more elements
Dependencies are inferred from the claim text.